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Author Response: Agreement between optometrists and ophthalmologists in the certification 
for vision impairment  
Dear Editor, 
 
We appreciate the interest of Jawaid et al.1 in our recent paper.2 The comparison of raters to 
a consensus panel to determine agreement has been widely used in medicine.3-6 We sought 
to undertake a comparison against a standardised outcome, determined by a consensus 
panel, rather than the assessment of absolute differences between groups. The former is 
more meaningful and reliable in the context of the underlying goal of the analysis, to 
evidence whether low vision optometrists have the appropriate ability in the certification 
process for vision impairment. 
 
We agree with the sensitivity and specificity values calculated by Jawaid et al.1 However, 
given that such values rely on the underlying assumption that the true state is known, the 
presentation of agreement values is more appropriate to our study. 
 
Any judgement on the performance of the raters is relative and fails to appreciate the 
importance of the finding of equivalence in outcomes between the optometrists and 
ophthalmologists. Indeed, variation in opinion between clinicians on patient management is 
not uncommon.7,8 
 
The background information in each case was identical to that in the original medical 
records. We would like to highlight the methodological importance of presenting identical 
information to each rater, rather than the format of the information itself. Nevertheless, we 
acknowledge the subjective nature of the clinical task under evaluation.  
  
We consider that it would be misleading to rely on visual acuity (VA) measurements alone, 
given the lack of precision of this measure of visual function, especially at poor levels of 
VA.9,10 Both VA and visual field outcomes were considered together by the participants, in 
order to represent the clinical task. However, an investigation of the differences in 
interpretation with respect to each outcome was not undertaken systematically and may be 
warranted.  
 
Jawaid et al.1 suggest eligibility should include the global index, Mean Deviation (MD). The 
MD does not allow for the separation of generalised and localised loss and is dependent 
upon the level of media opacity,11 thus complicating interpretation. Another complication is 
the considerable variability of the visual field at -22dB MD.12, 13 Furthermore, such criteria 
exclude individuals with significant fixation instability e.g. late age-related macular 
degeneration (AMD), in whom a reliable visual field outcome may not be possible. 
 
Finally, we wish to highlight the impact of our findings on patients, given the potential for 
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